579 related articles for article (PubMed ID: 18566465)
41. Delta(9)-Tetrahydrocannabinol enhances MCF-7 cell proliferation via cannabinoid receptor-independent signaling.
Takeda S; Yamaori S; Motoya E; Matsunaga T; Kimura T; Yamamoto I; Watanabe K
Toxicology; 2008 Mar; 245(1-2):141-6. PubMed ID: 18249480
[TBL] [Abstract][Full Text] [Related]
42. Molecular and cellular changes induced by the activation of CB2 cannabinoid receptors in trabecular meshwork cells.
He F; Song ZH
Mol Vis; 2007 Jul; 13():1348-56. PubMed ID: 17679938
[TBL] [Abstract][Full Text] [Related]
43. Endocannabinoids enhance lipid synthesis and apoptosis of human sebocytes via cannabinoid receptor-2-mediated signaling.
Dobrosi N; Tóth BI; Nagy G; Dózsa A; Géczy T; Nagy L; Zouboulis CC; Paus R; Kovács L; Bíró T
FASEB J; 2008 Oct; 22(10):3685-95. PubMed ID: 18596221
[TBL] [Abstract][Full Text] [Related]
44. Pharmacological evaluation of LH-21, a newly discovered molecule that binds to cannabinoid CB1 receptor.
Chen RZ; Frassetto A; Lao JZ; Huang RR; Xiao JC; Clements MJ; Walsh TF; Hale JJ; Wang J; Tong X; Fong TM
Eur J Pharmacol; 2008 Apr; 584(2-3):338-42. PubMed ID: 18336811
[TBL] [Abstract][Full Text] [Related]
45. Interleukin-1 receptor-1-deficient mice show attenuated production of ocular surface inflammatory cytokines in experimental dry eye.
Narayanan S; Corrales RM; Farley W; McDermott AM; Pflugfelder SC
Cornea; 2008 Aug; 27(7):811-7. PubMed ID: 18650668
[TBL] [Abstract][Full Text] [Related]
46. Expression of cannabinoid receptors type 1 and type 2 in non-Hodgkin lymphoma: growth inhibition by receptor activation.
Gustafsson K; Wang X; Severa D; Eriksson M; Kimby E; Merup M; Christensson B; Flygare J; Sander B
Int J Cancer; 2008 Sep; 123(5):1025-33. PubMed ID: 18546271
[TBL] [Abstract][Full Text] [Related]
47. Isolation of human conjunctival mast cells and epithelial cells: tumor necrosis factor-alpha from mast cells affects intercellular adhesion molecule 1 expression on epithelial cells.
Cook EB; Stahl JL; Miller ST; Gern JE; Sukow KA; Graziano FM; Barney NP
Invest Ophthalmol Vis Sci; 1998 Feb; 39(2):336-43. PubMed ID: 9477991
[TBL] [Abstract][Full Text] [Related]
48. Anandamide induces cell death through lipid rafts in hepatic stellate cells.
Yang Q; Liu HY; Zhang YW; Wu WJ; Tang WX
J Gastroenterol Hepatol; 2010 May; 25(5):991-1001. PubMed ID: 20059638
[TBL] [Abstract][Full Text] [Related]
49. Modulation of the cannabinoid CB2 receptor in microglial cells in response to inflammatory stimuli.
Maresz K; Carrier EJ; Ponomarev ED; Hillard CJ; Dittel BN
J Neurochem; 2005 Oct; 95(2):437-45. PubMed ID: 16086683
[TBL] [Abstract][Full Text] [Related]
50. CB2 cannabinoid receptors in trabecular meshwork cells mediate JWH015-induced enhancement of aqueous humor outflow facility.
Zhong L; Geng L; Njie Y; Feng W; Song ZH
Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):1988-92. PubMed ID: 15914613
[TBL] [Abstract][Full Text] [Related]
51. Toll-like receptor 4 initiates an innate immune response to lipopolysaccharide in human conjunctival epithelial cells.
Chung SH; Kweon MN; Lee HK; Choi SI; Yang JY; Kim EK
Exp Eye Res; 2009 Jan; 88(1):49-56. PubMed ID: 18951893
[TBL] [Abstract][Full Text] [Related]
52. Regulation of opioid and cannabinoid receptor genes in human neuroblastoma and T cells by the epigenetic modifiers trichostatin A and 5-aza-2'-deoxycytidine.
Börner C; Martella E; Höllt V; Kraus J
Neuroimmunomodulation; 2012; 19(3):180-6. PubMed ID: 22262103
[TBL] [Abstract][Full Text] [Related]
53. Expression and function of cannabinoid receptors CB1 and CB2 and their cognate cannabinoid ligands in murine embryonic stem cells.
Jiang S; Fu Y; Williams J; Wood J; Pandarinathan L; Avraham S; Makriyannis A; Avraham S; Avraham HK
PLoS One; 2007 Jul; 2(7):e641. PubMed ID: 17653268
[TBL] [Abstract][Full Text] [Related]
54. Cannabinoid CB
Olianas MC; Dedoni S; Onali P
Life Sci; 2021 Jul; 276():119407. PubMed ID: 33794254
[TBL] [Abstract][Full Text] [Related]
55. Immunolocalization of cannabinoid receptor type 1 and CB2 cannabinoid receptors, and transient receptor potential vanilloid channels in pterygium.
Assimakopoulou M; Pagoulatos D; Nterma P; Pharmakakis N
Mol Med Rep; 2017 Oct; 16(4):5285-5293. PubMed ID: 28849159
[TBL] [Abstract][Full Text] [Related]
56. In vitro evidence of nerve growth factor effects on human conjunctival epithelial cell differentiation and mucin gene expression.
Lambiase A; Micera A; Pellegrini G; Merlo D; Rama P; De Luca M; Bonini S; Bonini S
Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4622-30. PubMed ID: 19407015
[TBL] [Abstract][Full Text] [Related]
57. Cannabinoids inhibit human keratinocyte proliferation through a non-CB1/CB2 mechanism and have a potential therapeutic value in the treatment of psoriasis.
Wilkinson JD; Williamson EM
J Dermatol Sci; 2007 Feb; 45(2):87-92. PubMed ID: 17157480
[TBL] [Abstract][Full Text] [Related]
58. CB1 and CB2 cannabinoid receptor expression during development and in epileptogenic developmental pathologies.
Zurolo E; Iyer AM; Spliet WG; Van Rijen PC; Troost D; Gorter JA; Aronica E
Neuroscience; 2010 Sep; 170(1):28-41. PubMed ID: 20621164
[TBL] [Abstract][Full Text] [Related]
59. LY320135, a novel cannabinoid CB1 receptor antagonist, unmasks coupling of the CB1 receptor to stimulation of cAMP accumulation.
Felder CC; Joyce KE; Briley EM; Glass M; Mackie KP; Fahey KJ; Cullinan GJ; Hunden DC; Johnson DW; Chaney MO; Koppel GA; Brownstein M
J Pharmacol Exp Ther; 1998 Jan; 284(1):291-7. PubMed ID: 9435190
[TBL] [Abstract][Full Text] [Related]
60. Cannabinoid receptor 1 but not 2 mediates macrophage phagocytosis by G(α)i/o /RhoA/ROCK signaling pathway.
Mai P; Tian L; Yang L; Wang L; Yang L; Li L
J Cell Physiol; 2015 Jul; 230(7):1640-50. PubMed ID: 25545473
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
